ALK inhibitors downregulate the expression of death receptor 4 in ALK-mutant lung cancer cells via facilitating Fra-1 and c-Jun degradation and subsequent AP-1 suppression
Article in Neoplasia (May 2023)
The most recent citing publications are shown below. View all 23 publications that cite this research output on Dimensions.
Molecular dissection of anti-colon cancer activity of NARI-29: special focus on H2O2 modulated NF-κB and death receptor signaling
Article in Free Radical Research (April 2023)
Niclosamide nanocrystal for enhanced in-vivo efficacy against gastrointestinal stromal tumor via regulating EGFR/STAT-3/DR-4 axis
Article in Journal of Drug Delivery Science and Technology (March 2023)